Cannara Biotech (TSXV:LOVE) Days Inventory : 286.07 (As of Nov. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Cannara Biotech's Average Total Inventories for the three months ended in Nov. 2023 was C$35.26 Mil. Cannara Biotech's Cost of Goods Sold for the three months ended in Nov. 2023 was C$11.25 Mil. Hence, Cannara Biotech's Days Inventory for the three months ended in Nov. 2023 was 286.07.

The historical rank and industry rank for Cannara Biotech's Days Inventory or its related term are showing as below:

TSXV:LOVE' s Days Inventory Range Over the Past 10 Years
Min: 168.95 Med: 262.01 Max: 334.06
Current: 310.18

During the past 6 years, Cannara Biotech's highest Days Inventory was 334.06. The lowest was 168.95. And the median was 262.01.

TSXV:LOVE's Days Inventory is ranked worse than
85.2% of 973 companies
in the Drug Manufacturers industry
Industry Median: 157.9 vs TSXV:LOVE: 310.18

Cannara Biotech's Days Inventory declined from Nov. 2022 (363.46) to Nov. 2023 (286.07).

Inventory Turnover measures how fast the company turns over its inventory within a year. Cannara Biotech's Inventory Turnover for the three months ended in Nov. 2023 was 0.32.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Cannara Biotech's Inventory-to-Revenue for the three months ended in Nov. 2023 was 1.81.

Cannara Biotech Days Inventory Historical Data

The historical data trend for Cannara Biotech's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Days Inventory Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Days Inventory

Get a 7-Day Free Trial

168.95

334.06

262.01

260.18

320.59

Cannara Biotech Quarterly Data
	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
Days Inventory	Get a 7-Day Free Trial															363.46	267.33	353.67	345.91	286.07

Competitive Comparison of Cannara Biotech's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Days Inventory distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Days Inventory falls into.

Cannara Biotech Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Cannara Biotech's Days Inventory for the fiscal year that ended in Aug. 2023 is calculated as

	Days Inventory (A: Aug. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Aug. 2022 )	+	Total Inventories (A: Aug. 2023 ))	/	count )	/	Cost of Goods Sold (A: Aug. 2023 )	*	Days in Period
=	( (18.979	+	33.772)	/	2 )	/	30.029	*	365
=	26.3755					/	30.029	*	365
=	320.59

Cannara Biotech's Days Inventory for the quarter that ended in Nov. 2023 is calculated as:

	Days Inventory (Q: Nov. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Aug. 2023 )	+	Total Inventories (Q: Nov. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Nov. 2023 )	*	Days in Period
=	( (33.772	+	36.754)	/	2 )	/	11.248	*	365 / 4
=	35.263					/	11.248	*	365 / 4
=	286.07

Cannara Biotech (TSXV:LOVE) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Cannara Biotech's Inventory Turnover for the three months ended in Nov. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	11.248	/	35.263
	=	0.32

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Cannara Biotech's Inventory to Revenue for the three months ended in Nov. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	35.263	/	19.483
	=	1.81

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Cannara Biotech Days Inventory Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (TSXV:LOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .